Back to AQR CAPITAL MANAGEMENT LLC AQR CAPITAL MANAGEMENT LLC

ARCTARCT
Showing 8 of 16 quarters

Position history for AQR CAPITAL MANAGEMENT LLCAQR CAPITAL MANAGEMENT LLC's holdings in ARCTURUS THERAPEUTICS HLDGS

AQR CAPITAL MANAGEMENT LLC holds 675,014 shares of ARCT (ARCTURUS THERAPEUTICS HLDGS), worth $4.5M as of 2026-Q2. The position was increased (+318.5% shares). ARCT represents 0.0% of AQR CAPITAL MANAGEMENT LLC's portfolio.

Current Value

$4.5M

Current Shares

675,014

Total Value Change

+$4.3M

Total Shares Change

+662,936

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
675,014
+318.5%
$4.5M0.0%$6.72
43
2026-Q1
Increased
161,278
+271.6%
$1.2M0.0%$7.91
41
2025-Q4
New
43,403
-
$266,0600.0%$6.19
32
2025-Q3
Exited
0
-100.0%
$00.0%$18.78
0
2025-Q2
Decreased
11,218
-7.0%
$145,9460.0%$13.33
0
2025-Q1
New
12,067
-
$127,7900.0%$11.58
31
2024-Q4
Exited
0
-100.0%
$00.0%$16.58
0
2024-Q3
Increased
12,078
+3.2%
$280,3310.0%$22.03
24

Other major holders of ARCT: BNP PARIBAS FINANCIAL MARKETS, ARK Investment Management LLC, FEDERATED HERMES, INC.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used